Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the house dust mite allergy market size evolved in recent years?

The market for house dust mite allergy has seen a swift expansion in the recent past. Its progression from $2.11 billion in 2024 to $2.39 billion in 2025, at a compound annual growth rate (CAGR) of 13.0%, points to the same. The notable growth over the historical period could be tied back to factors such as heightened awareness and education, progress in diagnostic instruments, research, and clinical trials, enhancement of healthcare facilities, and regulatory norms and standards.

What are the predictions for the house dust mite allergy market size in the coming years?

The market for house dust mite allergy is anticipated to witness speedy expansion in the upcoming years, reaching $4.1 billion in 2029 with a compound annual growth rate (CAGR) of 14.5%. This predicted growth during the forecast period can be associated with elements like regulatory backing and allergen labeling, the surging frequency of allergies, the rise in telemedicine and distant care, amplified emphasis on precision medicine, and the proliferation of allergen-avoidance products. Key trends expected during this prediction period comprise public health enlightenment campaigns, the incorporation of digital health solutions, the emphasis on the quality of indoor environments, the expansion in immunotherapy solutions, and progressions in allergen avoidance products.

Get your house dust mite allergy market report here!

https://www.thebusinessresearchcompany.com/report/house-dust-mite-allergy-global-market-report

What key factors are fueling the growth of the house dust mite allergy market?

The rise in asthma diseases is projected to fuel the expansion of the house dust mite allergy market. Asthma is a disorder that results in the constriction and swelling of airways, and in some cases, the excessive production of mucus that can impact lung function and cause breathing difficulties. Asthma patients are particularly susceptible to dust in their surroundings, often exacerbating their allergies and illness, and necessitating the use of numerous anti-allergy medications. Consequently, the growing incidence of asthma diseases heightens the need for house dust mite allergy treatments. For example, the Asthma and Allergy Foundation of America, a community-based organization in the U.S., reported in September 2024 that around ten individuals die from asthma each day in the U.S., amounting to 3,235 deaths in 2022. A majority of these deaths could be averted with suitable treatment and care. Thus, the surge in asthma diseases is bolstering the house dust mite allergy market.

How is the global house dust mite allergy market divided into key segments?

The house dust mite allergy market covered in this report is segmented –

1) By Product Type: Tablets, Nasal Drops, Injectable

2) By Treatment Type: Medication, Immunotherapy, Nasal Irrigation, Other Types

3) By Diagnosis: Skin Prick Test (SPT), Specific Immunoglobulin E (IgE) Blood Test, Other Diagnosis

4) By Dosage Forms: Solid, Liquid

5) By End Users: Hospitals, Homecare, Specialty Clinics, Other End Users

Subsegments:

1) By Tablets: Sublingual Tablets, Oral Tablets

2) By Nasal Drops: Antihistamine Nasal Drops, Corticosteroid Nasal Drops

3) By Injectable: Allergen Immunotherapy Injections, Corticosteroid Injections

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9304&type=smp

Who are the key firms paving the way for growth in the house dust mite allergy market?

Major companies operating in the house dust mite allergy market include Allergy Therapeutics Plc, Bayer AG, Catalent Inc., GSK Plc, Merz Pharma GmbH & Co KGaA, Sanofi S A, Shionogi & Co. Ltd., Stallergenes Greer International AG, Merck & Co. Inc., Torii Pharmaceutical Co. Ltd., Ergomed PLC, DMS Group, HAL Allergy Group, Trio Lifescience Private Limited, Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, Johnson and Johnson Inc., Circassia Pharmaceuticals Plc, Biomay Ag, GlaxoSmithKline

Which trends are expected to transform the house dust mite allergy market?

The primary companies in the house dust mite allergy market are focusing on developing creative solutions, such as sublingual tablets to tackle the growing prevalence of allergies. A sublingual tablet meant for house dust mite allergies is a form of immunotherapy that involves placing a tablet under the tongue. The tablet dissolves and releases minute doses of the allergen causing the allergy. For example, in January 2023, Denmark-based pharmaceutical company ALK-Abelló A/S received FDA approval for ODACTRA, a sublingual tablet designed to treat adolescents aged 12 to 17 with house dust mite allergies, broadening its previous usage for adults. This approval addresses a crucial requirement as about 50% of individuals with allergies are sensitive to house dust mites. Clinical trials illustrated that ODACTRA effectively diminishes allergy symptoms, maintaining a safety profile akin to what was observed in adults. Although the treatment is typically well-received, patients are encouraged to have auto-injectable epinephrine accessible due to the potential for severe allergic reactions.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9304

What regions are contributing significantly to the growth of the house dust mite allergy market?

North America was the largest region in the house dust mite allergy market in 2024. Asia-pacific is expected to be the fastest-growing region in the house dust mite allergy market report during the forecast period. The regions covered in the house dust mite allergy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Ophthalmology Drugs Global Market Report 2022

https://www.thebusinessresearchcompany.com/report/ophthalmology-drugs-global-market-report

Diagnostic Enzyme Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/diagnostic-enzymes-global-market-report

Pediatric Vaccine Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pediatric-vaccine-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: